You have 9 free searches left this month | for more free features.

Levoleucovorin

Showing 1 - 25 of 653

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Colorectal Cancer Trial (cadonilimab, irinotecan, Oxaliplatin)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 20, 2023

Locally Advanced Unresectable or Metastatic Esophageal Cancer Trial (Futibatinib, Pembrolizumab, Cisplatin)

Not yet recruiting
  • Locally Advanced Unresectable or Metastatic Esophageal Cancer
  • (no location specified)
Jul 6, 2023

Colorectal Tumors, Tumor Metastasis, Colonic Tumors Trial in Seoul (Atezolizumab, Bevacizumab, Oxaliplatin)

Active, not recruiting
  • Colorectal Neoplasms
  • +3 more
  • Seoul, Songpa-gu, Korea, Republic of
    Asan Medical Center
Jul 6, 2022

Autism Spectrum Disorder, Language Disorders Trial in Phoenix, Brooklyn (Levoleucovorin Calcium, Placebo)

Active, not recruiting
  • Autism Spectrum Disorder
  • Language Disorders
  • Levoleucovorin Calcium
  • Placebo
  • Phoenix, Arizona
  • +1 more
Sep 26, 2022

Autism Spectrum Disorder, Language Disorders Trial in Phoenix, Brooklyn (Levoleucovorin Calcium, Placebo)

Active, not recruiting
  • Autism Spectrum Disorder
  • Language Disorders
  • Levoleucovorin Calcium
  • Placebo
  • Phoenix, Arizona
  • +1 more
Oct 7, 2022

Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in France, United Kingdom, United States (NUC-3373 +

Recruiting
  • Colorectal Cancer
  • +4 more
  • NUC-3373 + leucovorin
  • +8 more
  • Boston, Massachusetts
  • +9 more
Jan 23, 2023

Colonic Tumors Trial in Gothenburg (6R-MTHF (arfolitixorin) 200 mg/m2, Levoleucovorin 200 mg/m2, 6R-MTHF (arfolitixorin) 60

Completed
  • Colonic Neoplasms
  • 6R-MTHF (arfolitixorin) 200 mg/m2
  • +3 more
  • Gothenburg, Sweden
    Sahlgrenska University Hospital
Sep 7, 2020

Colorectal Tumors Trial in United States (tucatinib, trastuzumab, bevacizumab)

Recruiting
  • Colorectal Neoplasms
  • Anaheim, California
  • +13 more
Aug 15, 2022

Non Hodgkin's Lymphoma Trial (Fusilev, Folotyn)

Withdrawn
  • Non Hodgkin's Lymphoma
  • (no location specified)
Jan 21, 2020

NSCLC Trial (Folotyn, Fusilev)

Withdrawn
  • Non-Small Cell Lung Cancer
  • (no location specified)
Jan 21, 2020

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage I Pancreatic Cancer Trial in United

Active, not recruiting
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • Fairfield, Connecticut
  • +8 more
Oct 31, 2022

NSCLC, Mesothelioma, Thymoma Trial in Breda, Dordrecht (Folinic acid)

Recruiting
  • NSCLC
  • +2 more
  • Folinic acid
  • Breda, Noord Brabant, Netherlands
  • +1 more
Aug 17, 2023

Rectal Cancer Trial in Korea, Republic of (radiation, drug, procedure)

Recruiting
  • Rectal Cancer
  • short-course radiotherapy
  • +3 more
  • Daegu, Korea, Republic of
  • +8 more
Jan 8, 2023

Rectal Cancer Trial (PD-1, SCRT, Bevacizumab)

Not yet recruiting
  • Rectal Cancer
  • (no location specified)
Dec 6, 2022

High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai

Recruiting
  • High-risk Stage II Colorectal Cancer
  • +2 more
  • mFOLFIRINOX adjuvant chemotherapy
  • mFOLFOX6/XELOX adjuvant chemotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 12, 2023

First-line Treatment of Advanced Pancreatic Cancer Trial (HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate,

Not yet recruiting
  • First-line Treatment of Advanced Pancreatic Cancer
  • HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate
  • nab-paclitaxel; gemcitabine
  • (no location specified)
Feb 28, 2023

Esophageal Squamous Cell Carcinoma (ESCC), Gastroesophageal Junction Carcinoma (GEJC), Esophageal Adenocarcinoma (EAC) Trial in

Recruiting
  • Esophageal Squamous Cell Carcinoma (ESCC)
  • +2 more
  • pembrolizumab
  • +7 more
  • Long Beach, California
  • +158 more
Jan 19, 2023

Colorectal Cancer Metastatic Trial in Vejle (drug, dietary supplement, other)

Recruiting
  • Colorectal Cancer Metastatic
  • Vejle, Denmark
    Department of Oncology, Vejle Hospital
Nov 17, 2022

Colon Cancer Stage III Trial in Daejeon (FOLFOXIRI, mFOLFOX 6)

Recruiting
  • Colon Cancer Stage III
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
Dec 17, 2021

Gastric Cancer, Gastroesophageal-junction Cancer, Advanced Cancer Trial (TST001, CapOx or mFOLFOX6 and NIVO or (Substudy)

Not yet recruiting
  • Gastric Cancer
  • +2 more
  • TST001, CapOx or mFOLFOX6 and NIVO or (Substudy) TST001, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
  • Placebo CapOx or mFOLFOX6 and NIVO or (Substudy) Placebo, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
  • (no location specified)
Oct 16, 2023

Metastatic Colorectal Cancer Trial in Madrid (Aflibercept, Irinotecan, folinic acid (dl racemic))

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Madrid, Spain
    Spanish Cooperative Group for Digestive Tumour Therapy (TTD)
Oct 10, 2022

Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC

Recruiting
  • Locally Advanced Pancreatic Ductal Adenocarcinoma
  • +7 more
  • Gemcitabine Hydrochloride
  • +8 more
  • Philadelphia, Pennsylvania
  • +1 more
Dec 20, 2022

Pancreatic Ductal Adenocarcinoma Trial (NP137, Oxaliplatin, Irinotecan)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • (no location specified)
Sep 23, 2022

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, HER2-positive Gastric Cancer Trial in China

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Hangzhou, Zhejiang, China
  • +7 more
Feb 7, 2023

Gastric Cancer Stage IV Trial (Oxaliplatin, Levo-Leucovorin, 5-fluorouracil)

Not yet recruiting
  • Gastric Cancer Stage IV
  • (no location specified)
Nov 13, 2022